Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix

Proceedings of the National Academy of Sciences(2024)10.1073/pnas.2321898121Source: DataRank Database

Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix is a research paper published in Proceedings of the National Academy of Sciences (2024). On theSindex it has a DataRank of 0. It has been cited 18 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access18 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (12 grants)Impact (FWCI 5.06)OA: hybridTopics (60)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (38)

Kyungjo Jeong ORCID,Mari K. Halle ORCID,Camilla Krakstad ORCID,Blair McNamara ORCID,Michelle Greenman ORCID

Live enrichment

PubMed:38625939 PMC:PMC11046577 OpenAlex:https://openalex.org/W4394856611

HHS | NIH | NCI | Advancing Science and Practice in the Retail Environment

Grant: U01 CA176067-01A1

HHS | NIH | NCI | Advancing Science and Practice in the Retail Environment

Grant: CA-16359

National Research Foundation of Korea

Grant: NRF2022R1A4A2000827

NIH HHS

Grant: S10 OD030363

NCI NIH HHS

Grant: P30 CA008748

NCATS NIH HHS

Grant: UL1 TR001863

NCI NIH HHS

Grant: R01 CA269779

NCI NIH HHS

Grant: U01 CA176067

NCI NIH HHS

Grant: P30 CA016359

National Institutes of Health

Grant: 2P30CA016359-15

COMPREHENSIVE CANCER CENTER

National Institutes of Health

Grant: 5R01CA269779-03

Uncovering the Mechanisms of Metastasis in Fallopian Tube-Originated Ovarian Cancer

National Institutes of Health

Grant: 1U01CA176067-01A1

Integrated genomic analysis of racial disparities in endometrial cancer

FWCI

5.06

Citation Percentile

1.0%

Citation Trend

2024

2025

2026

hybridLicense: cc-by-nc-nd

journalhttps://www.pnas.org/doi/pdf/10.1073/pnas.2321898121

publisherhttps://www.pnas.org/doi/pdf/10.1073/pnas.2321898121

publisherhttps://pnas.org/doi/pdf/10.1073/pnas.2321898121

journalhttps://doi.org/10.1073/pnas.2321898121

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38625939

Fields of Study

Neuroendocrine Tumor Research AdvancesLung Cancer Research StudiesNeuroblastoma Research and Treatments0301 basic medicine0303 health sciences03 medical and health sciencesHumansFemaleUterine Cervical NeoplasmsAfatinibPhylogenyPhosphatidylinositol 3-KinasesNeuroendocrine TumorsMutationClass I Phosphatidylinositol 3-KinasesAdenocarcinomaCarcinoma, NeuroendocrineDNA Mutational Analysis

MeSH Terms

AfatinibAdenocarcinomaUterine Cervical NeoplasmsDNA Mutational AnalysisFemaleHumansMutationPhylogenyCarcinoma, NeuroendocrineNeuroendocrine TumorsPhosphatidylinositol 3-KinasesClass I Phosphatidylinositol 3-Kinases

Keywords

BiologyCancer researchPTENAdenocarcinomaExome sequencingHRASARID1AGeneGeneticsPI3K/AKT/mTOR pathwayMutationKRASCancerGenetic analysisNeuroendocrineOncogeneMutationsClass I Phosphatidylinositol 3-KinasesCarcinomaDNA Mutational Analysis610Uterine Cervical NeoplasmsBiological SciencesAfatinibCarcinoma, NeuroendocrinePhosphatidylinositol 3-KinasesNeuroendocrine TumorsHumansFemalePhylogeny

Sustainable Development Goals

SDG 0: Life in Land